Gregory Fiore
Oprichter bij Exacis Biotherapeutics, Inc.
Actieve functies van Gregory Fiore
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Exacis Biotherapeutics, Inc.
Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Directeur/Bestuurslid | 01-06-2020 | - |
Algemeen Directeur | 01-06-2020 | - | |
Oprichter | 01-06-2020 | - | |
President | 01-06-2020 | - |
Loopbaan van Gregory Fiore
Eerdere bekende functies van Gregory Fiore
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ETERNA THERAPEUTICS INC. | Directeur/Bestuurslid | 07-06-2022 | 03-10-2023 |
Sollis Therapeutics, Inc.
Sollis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sollis Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company developing novel non-steroid and non-opioid analgesics. The company was founded by Gregory Fiore and Bryan Jones and is headquartered in Columbus, OH. | Algemeen Directeur | 01-01-2017 | 01-01-2020 |
Hoofd Techniek/Wetenschap/O&O | 01-01-2019 | 01-01-2020 | |
Oprichter | 01-01-2017 | 01-01-2020 | |
Corporate Officer/Principal | 01-01-2019 | 01-01-2020 | |
President | 01-01-2017 | 01-01-2020 | |
Fiore Healthcare Advisors, Inc.
Fiore Healthcare Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SSI Strategy LLC, Fiore Healthcare Advisors, Inc. provides pharmacovigilance and clinical research consulting services. The company is based in Boston, MA. The company was founded by Gregory Fiore. Fiore Healthcare Advisors was acquired by SSI Strategy LLC on June 29, 2021. | Oprichter | - | - |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services SSI Strategy owns and operates boutique management consulting firm. Its services include global medical affairs transformation, competency model development, post-merger integration, launch preparation, emerging markets medical affairs: organizational transformation, pharmacovigilance system enhancement and medical planning and tactic prioritization. The company was founded by Gregory Fiore in 2010 and is headquartered in Parsippany, NJ. | Hoofd Techniek/Wetenschap/O&O | 01-01-2010 | - |
Oprichter | 01-01-2010 | - | |
THE MEDICINES COMPANY | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 | - |
Opleiding van Gregory Fiore
New York Medical College | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Founder | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Chief Executive Officer | 2 |
Sectoraal
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ETERNA THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services SSI Strategy owns and operates boutique management consulting firm. Its services include global medical affairs transformation, competency model development, post-merger integration, launch preparation, emerging markets medical affairs: organizational transformation, pharmacovigilance system enhancement and medical planning and tactic prioritization. The company was founded by Gregory Fiore in 2010 and is headquartered in Parsippany, NJ. | Commercial Services |
Sollis Therapeutics, Inc.
Sollis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sollis Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company developing novel non-steroid and non-opioid analgesics. The company was founded by Gregory Fiore and Bryan Jones and is headquartered in Columbus, OH. | Health Technology |
Exacis Biotherapeutics, Inc.
Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Health Services |
Fiore Healthcare Advisors, Inc.
Fiore Healthcare Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SSI Strategy LLC, Fiore Healthcare Advisors, Inc. provides pharmacovigilance and clinical research consulting services. The company is based in Boston, MA. The company was founded by Gregory Fiore. Fiore Healthcare Advisors was acquired by SSI Strategy LLC on June 29, 2021. | Commercial Services |
- Beurs
- Insiders
- Gregory Fiore
- Ervaring